Un simplu test la naștere ar putea depista copiii cu risc genetic de cancer înainte de apariția bolii: STUDIU

A recent study suggests that genetic testing at birth could identify children at risk for certain pediatric cancers, potentially improving early detection and treatment outcomes. Researchers analyzed blood samples from nearly 2,000 newborns who later developed tumors, finding pathogenic variants in 6.8% of cases. The study highlights the feasibility of integrating genetic screening into routine newborn checks, similar to existing screenings for other conditions. Early identification could lead to tailored medical surveillance and earlier diagnosis, significantly enhancing survival rates. However, ethical considerations regarding parental consent and the psychological impact on families remain critical challenges.